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Abstract 
Diabetes Mellitus (DM) is one of the greatest public health threats in modern societies. 
Although during a few years it was suggested that DM had no significant effect in male 
reproductive function, this view has been challenged in recent years. The increasing 
incidence of DM worldwide will inevitably result in a higher prevalence of this pathology 
in men of reproductive age and subfertility or infertility associated with DM is expected 
to dramatically rise in upcoming years. From a clinical perspective, the evaluation of 
semen parameters, as well as spermatozoa DNA integrity, are often studied due to 
their direct implications in natural and assisted conception. Nevertheless, recent 
studies based on the molecular mechanisms beyond glucose transport in testicular 
cells provide new insights in DM-induced alterations in male reproductive health. 
Testicular cells have their own glucose sensing machinery that react to hormonal 
fluctuations and have several mechanisms to counteract hyper- and hypoglycemic 
events. Moreover, the metabolic cooperation between testicular cells is crucial for 
normal spermatogenesis. Sertoli cells (SCs), which are the main components of blood-
testis barrier, are not only responsible for the physical support of germ cells but also for 
lactate production that is then metabolized by the developing germ cells. Any alteration 
in this tied metabolic cooperation may have a dramatic consequence in male fertility 
potential. Therefore, we present an overview of the clinical significance of DM in the 
male reproductive health with emphasis on the molecular mechanisms beyond glucose 
fluctuation and transport in testicular cells. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
3 
 
1. Introduction 
Diabetes Mellitus (DM) is one of the most prominent public health threats in modern 
societies and its prevalence is rapidly increasing. In 2000, the World Health 
Organization (WHO) reported that there were about 171 million people with DM, which 
represented a 60% increase relatively to 1995 [1]. A recent report by Wild and 
collaborators predicted that, if obesity rates are maintained constant, in 2030 there will 
be about 300 million individuals affected by DM, which could represent a 39% increase 
comparatively to 2000 [2]. However, the statistics that point to an overall 4.4% 
prevalence in the world population could be underestimated since the factors known to 
be responsible for the disease progression, such as obesity and lifestyle habits, may 
aggravate these numbers [2].  
A closer look into fertility rates of modern societies reveals that the increased incidence 
of DM has been closely associated with falling birth rates and fertility [3, 4]. This is due 
to a disturbing increase of diabetic men in reproductive age. The great majority of 
patients with type 1 diabetes ( 1D) are diagnosed before the age of 30 [5] and there is 
an alarming number of childhood and adolescent with T1D and type 2 diabetes (T2D) 
[6]. Moreover, western diets, lifestyle habits and obesity in young individuals strongly 
contribute for the increasing incidence of T2D in youth [7]. In Japan, there are already 
four times more adolescents with T2D than T1D [8], and, in USA, more than one third 
of the new DM diagnostics are in young adolescents [9]. Although there is no doubt 
that the disease is responsible for several pathological and biochemical alterations that 
reduce male fertility, the real impact of DM on male reproductive health remains 
obscure and is a matter of great debate. Sexual disorders, such as erectile dysfunction 
[10] or retrograde ejaculation [11, 12], are known to occur in diabetic individuals and 
usually end-up in a reduction of sexual appetite that is often attributed to lethargy and a 
certain degree of tiredness associated to the hyperglycemic state [13]. The decline in 
reproductive health of male diabetics can be apparently attenuated in a “well-
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controlled” patient but the discussion on the molecular mechanisms behind such 
processes is scarce. Multiple molecular mechanisms and pathways are affected by DM 
with dramatic consequences to male reproductive function. The endocrine control of 
spermatozoa production event, spermatogenesis, is in fact severely altered in DM [14-
16], and sperm quality and/or functioning of diabetic men can be compromised. This is 
a direct consequence of the unique characteristics of glucose metabolism that 
testicular cells present. Their glucose sensing machinery, hormonal control and specific 
mechanisms to counteract hyper- and hypoglycemia play a crucial role in the 
subfertility and/or infertility associated to DM.  
Several clinical and animal studies have been focused on the molecular mechanisms 
responsible for the alterations induced by DM in male reproductive potential but much 
remains to be discussed. Important metabolic pathways, beyond glucose transport to 
the cells, remain undisclosed. Moreover, insulin (dys)function in male diabetic 
individuals is scarcely debated in the interpretation of the mechanisms responsible for 
male DM-induced subfertility/infertility. Therefore, we aim to present an up-to-date view 
on the male reproductive health of diabetic individuals and discuss the molecular 
mechanisms and pathways altered by DM beyond the expected increase in glucose 
transport to testicular cells. The role of insulin signaling will also be discussed. Finally, 
future directions in the study of the molecular mechanisms responsible for DM-induced 
male reproductive dysfunction will be presented. 
 
2. Diabetes Mellitus at a glance 
Diabetes is a chronic, metabolic disease characterized by hyperglycemia that can 
result from defects in insulin secretion and/or insulin action [17]. Moreover, there is a 
severe alteration in carbohydrate, lipid and protein metabolism [17] that causes several 
systemic complications and co-morbidities such as renal failure or hypertension [18, 
19]. Therefore, the origin of the DM-induced dysfunctions is a result of multifactorial 
causes that cannot be disregarded and highly complicates the study of this disease. 
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The vast majority of the diagnosed DM cases are classified as T1D or T2D. In the first 
category, there is an absolute deficiency of insulin secretion, while in the second the 
cause can be a combination of insulin resistance and insufficient insulin secretion [17]. 
Noteworthy, in T2D the clinical symptoms are frequently detected only in an advanced 
phase of the disease, allowing the progression of functional changes in cells and 
tissues that may not be reverted even when a correct therapy is achieved [20]. One 
must also note that although the glycemic management in diabetic patients is crucial to 
reduce the development of several complications, it does not eliminate all the 
undesirable effects [21, 22]. Recent reports have questioned the safety of insulin [23] 
since some of the most important side-effects that diabetic patients suffer are related to 
the occurrence of hypoglycemic events, even if they occur transiently [24, 25]. 
Nevertheless, insulin remains the most powerful antihyperglycemic agent available 
although it is often combined with other antihyperglycemic agents to achieve 
euglycemia in diabetic patients. Noteworthy, recent studies reported that adults with 
DM can have a poor glycemic control due to intentionally missed insulin therapy [26] 
thus evidencing that clinical studies can, sometimes, be misled by this factor. 
The complexity of DM diagnostic, especially in obese patients, led the researchers to 
establish an intermediate state, often called as pre-diabetes, where the patients 
present mild glycaemia that does not meet the established criteria for DM. 
Nevertheless pre-diabetic patients have important metabolic alterations that increase 
the risk for T2D development [27] and associated complications. Besides mild 
glycaemia, pre-diabetic individuals also present impaired glucose tolerance and insulin 
secretion as well as relative insulin insensitivity [27, 28]. Thus, special care must be 
taken in account when discussing the overall effects of DM in any relevant 
physiological condition because the spectrum of development stages of this disease is 
very complex [29]. It is also well known that DM alters the hypothalamic-pituitary-
gonadal axis, which is responsible for some of the problems related to DM, such as 
impotence [16, 30]. Earlier studies reported elevated pituitary gonadotrophins in 
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diabetic rats [31] and altered levels of LH and FSH [32, 33]. Moreover, diabetic rats 
have abnormal sexual steroids feedback in the hypothalamic-pituitary axis described as 
a consequence of abnormal steroid transport or reduced pituitary sensitivity [15, 34]. 
Several reports also demonstrated that DM is associated with hormonal deregulation, 
particularly of sex steroids hormones [35-37].  
In summary, DM is a metabolic disease that is growing to epidemic proportions. 
Besides, there are several co-morbidities that highly increase the complexity of the 
disease. The human and economic costs of such a wide spectrum disease are beyond 
estimations, making DM a preferential spotlight for researchers all over the world.    
 
3. Molecular basis of glucose metabolism in testis and sperm 
Blood glucose concentrations depend on and alter the function of several organs and 
tissues. Liver and fat are usually known to suffer a tight control from glucose 
fluctuations, especially because they are known to play key roles in the use and 
storage of nutrients by hormonally regulated mechanisms. In testes, glucose 
metabolism is also a pivotal event. Moreover, spermatogenesis maintenance in vivo 
depends upon glucose metabolism [38] although there are low levels of this sugar in 
tubular fluid [39]. Therefore, blood-to-germ cells transport of glucose and other 
metabolic intermediates is highly controlled, particularly due to the presence of the 
blood-testis barrier (BTB). This barrier not only physically divides the seminiferous 
epithelium in two compartments but is also responsible for the maintenance of different 
levels of substances and metabolites between rete testis fluid and the lymph or plasma 
[40]. One of the most relevant testicular cells for all the functions of BTB is the Sertoli 
cell (SC). These cells have such an important role on male reproductive function that 
their number is usually associated with testis size [41] and they play a broad spectra of 
functions in the spermatogenic event. Besides being responsible for water transport 
from the interstitial space to the lumen [42], they also control the seminiferous fluid pH 
and ionic composition [43-45]. Furthermore, SCs are known as “nurse cells” because 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
7 
 
they provide physical and nutritional support for the developing germ cells, which is 
pivotal for a normal spermatogenesis [46]. SCs are well known for their ability to 
produce lactate at a higher rate [39, 46-50] that is consumed, together with pyruvate, 
by pachytene spermatocytes and round spermatids [46, 47, 51] (Fig. 1).  
Glucose passive transport across BTB, mediated by glucose transporters (GLUTs), is 
an important event to spermatogenesis. In SCs, the main components of BTB, GLUT1, 
GLUT3 and GLUT8 isoforms have been identified [52, 53]. GLUT1 and GLUT3 
expression proved to be sensitive to several substances such as hormones, cytokines 
or growth factors, which are known to regulate glucose uptake by SCs [49, 50, 53, 54]. 
Recent in vitro studies reported that when glucose [55] or insulin [54] are removed from 
extracellular medium, SCs are capable to adapt their glucose transport machinery in 
order to ensure the appropriate lactate production.  
In these processes, lactate dehydrogenase (LDH) is pivotal for the continued ATP 
production by glycolysis. Moreover, germ cells express a specific isozyme of LDH, 
known as LDH type C (LDHC) that is abundant in spermatids and spermatozoa [56, 
57]. After glucose uptake by SCs and the conversion of pyruvate to lactate by LDH, it is 
imperative that this product of glycolysis becomes available for the developing germ 
cells. This event is mediated by active membrane monocarboxylate transporters 
(MCTs) that are responsible for lactate transport through the plasma membrane of SCs 
[49, 54, 55, 58] (Fig. 1). We [49, 50, 59] and others [53, 60, 61] reported that the 
testicular cells metabolic cooperation is under strict hormonal control leading us to 
conclude that the hormonal control of SCs metabolism is pivotal for spermatogenesis 
[62]. Therefore, understanding SCs energy metabolism may help to identify and 
promote new therapeutic approaches against subfertility or infertility caused by 
pathological conditions as spermatogenesis is in the basis of male fertility. 
The molecular basis of glucose metabolism and the importance of its subproducts in 
testis are far beyond the simple maintenance of the germ cells nutritional status. In fact, 
a vast majority of patients suffering from subfertility and infertility have problems in 
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sperm function rather than lack of sperm [63]. The ATP levels in sperm are maintained 
by several glycolytic and non-glycolytic substrates since both glycolysis and 
mitochondrial respiration are active in mammalian sperm [64]. However, sperm 
capacitation is known to be stimulated by glucose [65], evidencing the regulatory role 
that this sugar can exert in the overall male reproductive function. Importantly, the loss 
of sperm functional competence is often associated to oxidative stress that arises from 
sperm metabolism [66], since sperm capacitation is achieved by biochemical and 
metabolic modifications.   
 
4. Diabetes-related male subfertility/infertility 
a) Clinical Data 
Recently, a high prevalence (51%) of subfertility was reported among patients with DM 
[67]. This led to the perception that DM is responsible for inducing subtle but crucial 
changes in sperm quality and function [68]. It is well known that in men DM is 
responsible for important sexual disorders such as decreased libido and impotence 
[69]. Erectile dysfunction (ED) is also very prevalent in diabetic men [70], but it 
ultimately depends on the male age, the duration of the disease and the level of blood 
glucose levels control. In a population-based cohort study, there was an increase of ED 
in older men with DM [71] and it has been reported that the glycemic control is 
correlated with ED [72]. Ejaculation disturbance is another factor that has been long 
identified in men with DM, especially retrograde ejaculation [73, 74], a condition where 
semen passes backwards into the bladder.  
Diabetic male reproductive capacity is undoubtedly affect by ED and retrograde 
ejaculation, but when studying sperm parameters and sperm quality markers, the 
literature shows some conflicting results. In the 70’s a study involving 25 diabetic 
individuals and 24 control individuals (16-22 years old), showed that T1D juveniles 
presented lower sperm values and significant differences in sperm motility and 
morphology [75]. A few years later, other study compared the ejaculated of 65 diabetic 
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and 77 control men and it was reported a negative effect of DM in the ejaculated. The 
parameters mostly affected were, in decreased order, sperm motility, morphology, 
volume and count [76]. Slightly different results were reported in a 1984 study, where 
T1D adolescents presented a minor, non-significant, decrease in sperm count relatively 
to control individuals [77]. The semen from these T1D adolescents had lower volume 
and motility, as well as altered morphology, and presented significantly higher fructose 
and glucose levels, evidencing that an ineffective metabolic control can be deleterious 
and/or responsible for the observed alterations in the semen [77]. Later, a study in 
testicular biopsies from impotent men with DM, concluded that the testes of impotent 
diabetic men presented ultrastructural lesions in apical SC cytoplasm and 
morphological changes in the interstitial compartment, thus suggesting spermatogenic 
disruption and subfertility or infertility problems [78]. Another work reported that T1D 
and T2D subjects had a significant increase in sperm count and concentration, and a 
significant decrease in sperm motility and semen volume [77]. Interestingly, the sperm 
morphology and the quality of sperm motility remained unaffected [79]. Spermatozoa 
motility of T1D patients was also evaluated by Niven and collaborators using a 
computerized image analysis system [80]. They reported no correlations between 
sperm motility and age, age of onset of DM and duration of DM. Nonetheless, when 
comparing the diabetic group with control subjects, they concluded that several 
parameters related to sperm motility, such as track speed, path velocity, progressive 
velocity, and lateral head displacement, were not altered. On the other hand, other 
sperm motility related parameters, such as linearity and linear index that analyze the 
straightness of swimming, were significantly greater in diabetic men [80]. The 
controversy about the real impact of DM in male reproductive health continued, and, in 
2002, a sperm cryopreservation study of patients with several diseases, including DM, 
reported that only the sperm from diabetic men presented significant differences in 
sperm parameters, namely in sperm counts [81]. More recently, a study with both T1D 
and T2D patients reported that diabetic men may present normal semen parameters, 
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or only a significant decrease in semen volume, but they have a higher level of damage 
in sperm nuclear and mitochondrial DNA than control individuals [5].   
There are apparently contradictory results concerning sperm motility and other male 
reproductive parameters when studying male diabetics. In fact, the conflicting nature of 
the existing data should be clarified. The fact that most of these studies are more 
focused on the clinical significance, rather than the molecular mechanisms behind DM-
induced alterations, may explain at some extend the lack of consensus. For instance, 
the conventional semen analysis that was used in several of these studies, has been 
recognized by some authors, as very limited in the determination of the fertility status 
[82]. Moreover, there are several factors very difficult to control such as the duration of 
the disease, the glycemic control, the type of treatment as well as all the comorbidities 
associated to DM that mask the outcomes of the works related with DM and male 
fertility. Molecular studies with sperm from diabetics are still scarce and most of the 
mechanisms through which sperm manage to attain their energy metabolism in diabetic 
men remain to be disclosed. Therefore, there is an urgent need for more studies 
focused on the molecular mechanisms beyond glucose transport in sperm of diabetic 
men. However, there is a more profound lack of literature concerning the effect of DM 
in the functioning of testicular cells. It is expected that the metabolic cooperation 
between testicular cells may be compromised. To surpass these issues, as 
experimentation in humans has great restrictions and in most cases the tested 
hypotheses are impossible to assess in human material, the use of animal models that 
allow a tight control over experimental conditions are of extreme importance.  
 
b) Animal Models data 
Interestingly, data from animal models are successful in demonstrating that DM impairs 
male fertility and it is responsible for alterations in the reproductive health of individuals. 
As expected, there are more studies with animal models than with clinical data 
concerning DM-related male infertility. Since the 70’s there are studies reporting a 
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reduced fertility in male diabetic rats [83] and in the early 80’s several reports using BB 
Wistar rats, a strain that spontaneously develop DM, described gonadal dysfunction in 
these animals [84, 85]. A few years later the first study with a DM rat model induced by 
streptozotocin (STZ) and insulin therapy was done, reporting that STZ-treated rats 
presented decreased sperm counts and motility and that insulin treatment was able to 
restore these parameters [86]. This study evidenced that glycemic control may play a 
key role in reducing DM-related subfertility or infertility problems. Concomitant with that 
hypothesis, it was reported in the early 90’s that long-term DM with sustained 
uncontrolled hyperglycemia is responsible for testicular dysfunction, resulting in 
decreased fertility potential [87]. Later it was described that STZ-induced DM male rats 
have altered sex behavior and diminished reproductive organ weight, testicular sperm 
content, epididymal sperm content, as well as sperm motility [88]. Studies on STZ-
treated diabetic rats also showed that DM may cause regression of epididymis, leading 
to a decrease in caput weight, corpus, and caudal regions. Those studies also 
described atrophic changes in the caput, corpus, and caudal epididymis that resulted in 
voiding of spermatozoa from the epididymal lumen [89]. Insulin treatment was able to 
prevent some of these deleterious effects but only on certain epididymal regions [89]. 
Additionally, others studied the fertilization ability of spermatozoa from male STZ-
induced diabetics and reported that these animals had a significant reproductive 
dysfunction that resulted from a decrease in the reproductive organ weights and in 
sperm counts, though not compromising sperm fertilizing ability using in utero 
insemination [90]. Also, a study comparing T1D and T2D using STZ-treated and Goto-
Kakizaki (GK) rats showed that hyperglycemia had an adverse effect in sperm 
concentration and motility [91]. More recently, Kim and Moley [92] studied diabetic 
male mice sperm quality and fertilization capacity as well as subsequent embryo 
development. They concluded that DM decreased sperm concentration and motility 
and may cause male subfertility by altering steroidogenesis [92]. Others reported that 
the offspring of diabetic female rats, presented altered testicular parameters during 
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fetal life, which can affect reproductive health during post puberty [93]. The offspring 
males presented increased number of seminiferous tubules besides thickness of the 
testicular capsule and reduced number of Leydig, Sertoli and spermatogonia cells [93].  
Although there are contradictory results concerning sperm motility and other male 
reproductive parameters in diabetic men, it seems more consensual that DM rat 
models present significant alterations that end-up in reduced male reproductive health 
(see table 1 for details). Nevertheless most of the works are not actually focused on the 
molecular mechanisms beyond glucose deregulation. The pathological alterations 
induced throughout the male reproductive tract of rodents are diverse in nature and 
although the histological changes are evident, most of the biochemical changes remain 
unknown. Thus, it is imperative to disclose the molecular mechanisms behind testicular 
cells metabolic dysfunction caused by DM to identify key points for possible therapeutic 
interventions.  
 
5. Role of insulin dysfunction in male infertility  
Euglycemia is very difficult to achieve in diabetic individuals although glycemic control 
is crucial to reduce DM-related complications [22]. In fact, hypoglycemia and the 
correlated hyperinsulinemia are common events in diabetic individuals. Glucose and 
insulin fluctuations lead to important molecular alterations that may result in detrimental 
effects to the reproductive health of the diabetic men. The undesirable effects of DM 
can be controlled depending on the DM type and the stage of the disease progression 
but hyperinsulinemia and hypoglycemia are common in both T1D and T2D [94, 95]. 
Moreover, throughout the diabetic individual’s life, especially T2D subjects, become 
progressively more insulin deficient and, consequently, more vulnerable to the 
undesirable effects of a poor glycemic control. Furthermore, contrarily to non-diabetic 
individuals that are very sensitive to small glucose or insulin variations in plasma, 
diabetic individuals gradually lose their sensitiveness to glucose and insulin [96, 97]. 
This is very important because, as discussed earlier, the number of diabetic 
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adolescents is increasing and their reproductive health may be compromised at a very 
early age. Noteworthy, although the use of insulin analogues and/or insulin is essential 
they do not guaranty total effectiveness. In addition, insulin therapy can be a double-
edged sword and its safety has been questioned [23-25]. Thus, it is imperative to 
discuss the molecular mechanisms altered in testicular cells when insulin deregulation 
occurs. 
Few studies have been focused on the molecular mechanisms that are altered in 
testicular cells by insulin deregulation. In the early 80’s the first studies concerning the 
effect of insulin in SCs glucose metabolism were published. Initially, it was reported 
that insulin acted synergistically with other hormones but its importance to male 
reproduction remained unknown [98]. Others reported that insulin stimulated the uptake 
of total nucleotide pool and in ATP, GTP, and UTP pools [99] as well as transferrin 
secretion by SCs [100]. Then, it was reported that insulin at micromolar concentrations 
induced stimulatory effects not only in DNA and protein synthesis but also in SCs 
lactate production [101]. Later, it was reported that after 3 hours of insulin addition to 
SCs, they showed a marked stimulation of lactate production [102] (Fig. 2). This insulin 
effect on cultured immature rat SCs was described as being mediated by insulin 
receptors [102] (Fig. 2), however it was only a few years later that the authors reported 
not only the presence of insulin receptors but also suggested that insulin and insulin-
like growth factor-I (IGF-I) had precise functions responsible for the regulation of 
specific SCs activities during spermatogenesis initiation and maintenance [103, 104]. 
Interestingly, Leydig cells cultured in a Sertoli cell-conditioned medium had also their 
functions controlled by the presence or absence of insulin [105]. In the 90’s it was 
reported that insulin could not only regulate glycine metabolism but also lipid 
metabolism in cultured SCs [106]. Later, a study in SCs and Leydig cells of STZ-
treated rats, evidenced that the biosynthesis of arachidonic acid, a polyunsaturated 
fatty acid essential for several cellular functions, was under insulin regulation [107] (Fig. 
2). Importantly, it was reported that insulin could promote the differentiation of 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
14 
 
spermatogonia into primary spermatocytes by binding to the IGF-I receptor [108]. More 
recently, it was suggested that insulin restores the reproductive health in diabetic males 
by the normalization of the hypothalamic-pituitary-gonadal axis, and thus via the LH 
and testosterone levels, rather than having a direct interaction in the testis [109]. 
However, it was also recently reported that insulin deprivation induced several 
important metabolic alterations in cultured SCs [54, 59]. Insulin-deprived cultured SCs 
presented lower glucose consumption that was followed by a lower lactate production, 
down-regulation of metabolism-associated genes of lactate production and export and 
also an intriguing modulation of GLUT1 and GLUT3 [54] (Fig. 2). Noteworthy, acetate 
secretion, which is also reported to be one of the major SCs functions, was completely 
suppressed by SCs cultured under insulin deprivation conditions [59]. Although the 
exact meaning of this mechanism to spermatogenesis was not completely disclosed, 
the reduction of acetate production, necessary for the continuous membrane 
remodeling that occurs in the developing germ cells, may compromise the 
spermatogenic event.   
Insulin role on the male reproductive tract goes far beyond testicular cells. In the 70’s 
the first studies pointed to a stimulation of hexoses metabolism by sperm under insulin 
action [110]. However, the discussion continued whether insulin could modulate sperm 
metabolism or not with a study reporting that spermatozoa glucose oxidation could be 
independent from extracellular glucose concentration and insulin was not able to alter 
neither glucose metabolism nor spermatozoa motility [111]. A few years later, it was 
reported that both plasma membrane and the acrosome of spermatozoa are targets for 
insulin action and thus are under insulin hormonal control [112]. Also, intratesticular 
injection of insulin resulted in a decrease in spermatozoa motility in vas deferens and 
an increase in motile spermatozoa percentage on incubation medium after removal 
[113]. Moreover, defects in insulin secretion may change testicular and sexual glands 
function [114]. Interestingly, a study about the incidence of insulin resistance in men 
with ED, concluded that these men have a high incidence of insulin resistance thus 
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evidencing a possible role for insulin in the reproductive health of men [115]. Others 
also reported that in men with increased insulin resistance there is a decrease in 
Leydig cell testosterone secretion and, thus, severe male reproductive dysfunction 
[116]. Importantly, a recent study from Aquila and collaborators [117] proved that not 
only human ejaculated spermatozoa secrete insulin, as there is a physiological role for 
this insulin in the autocrine glucose metabolism regulation. This finding opened a new 
possible role for insulin in spermatozoa capacitation by controlling their glucose 
metabolic pathways. Others have also reported that insulin treatment in washed human 
spermatozoa from normozoospermic donors significantly increased total and 
progressive motility and acrosome reaction, as well as nitric oxide (NO) production, 
thus evidencing that insulin can enhance human spermatozoa fertilization capacity 
[118]. Moreover, a mitochondrial citrate carrier that contributes to the acquisition of 
sperm fertilizing ability through insulin secretion control has been identified [65], 
showing that insulin can act in sperm metabolism in a more complex way than the first 
proposed mechanisms.  
In sum, from the literature overview we conclude that insulin dysfunction has a crucial 
role in male infertility and/or subfertility related to DM and it is vital to study how insulin 
and insulin analogues therapy is administered and used to maintain the glycemic 
control. Moreover, insulin-induced hypoglycemia, a phenomenon that is frequent and in 
some rare cases fatal, has unpredictable effects in the overall metabolism of testicular 
cells. In fact, neither the magnitude of insulin dysfunction nor the mechanisms by which 
insulin controls testicular cells and sperm metabolism are fully disclosed. This issue 
should deserve more attention in the future. 
 
6. Molecular mechanisms of testicular glucose metabolism in diabetic conditions 
There is no doubt that spermatogenesis is a metabolically active process that depends 
upon strict metabolic cooperation between the several testicular cell types. During 
spermatogenesis, spermatozoa are produced within the seminiferous tubule in a 
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process that takes several days and is under endocrine and paracrine control through 
the SCs [10]. In addition, SCs are responsible for the conversion of glucose, a non-
metabolized substrate by developing germ cells, in lactate which is the preferential 
substrate for those cells. The molecular mechanisms of testicular glucose metabolism 
in diabetic conditions are far from being disclosed. Nevertheless, in vitro and 
morphological studies of human biopsies from diabetic men allowed the collection of 
small but vital information concerning those molecular mechanisms. Human biopsies 
from diabetic men showed that there are morphological changes in testicular cells, 
namely in SCs, which presented extensive vacuolization and had a high degree of 
degeneration [78]. Moreover, germ cells exhibited a normal morphology, but the 
seminiferous tubules were depleted, and the number of Leydig cells was also very 
variable, with these cells presenting lipid droplets and variable number of vacuoles [78]. 
All these changes certainly have dramatic consequences to testicular cells glucose 
metabolism and to the overall metabolic cooperation between SCs and developing 
germ cells. In fact, impairment of glucose metabolism is often related with increased 
fatty acid metabolism. Early studies reported that DM caused an increased 
endogenous oxygen uptake and reduced lactate production by testicular cells [119]. 
The same study also reported that DM increased cholesterol, non-esterified fatty acids, 
triglycerides and phospholipids in rat testis tissues [119]. In the 80’s, Hutson [120] 
studied the biochemical responses of rat SCs and peritubular cells cultured under 
simulated diabetic conditions and reported that the in vitro metabolic functioning of 
these testicular cells was very sensitive to glucose concentrations. In fact, SCs cultured 
with high glucose concentration increased lactate secretion. At that time, it had already 
been reported that lactate enhanced respiration rates and protein and RNA synthesis in 
isolated pachytene spermatocytes and round spermatids [47], by interacting in other 
metabolic pathways and producing adenosine triphosphate (ATP) [121]. Besides, 
lactate was also described as a modulator of nicotinamide adenine dinucleotide 
phosphate-oxidase (NADH) oxidation and the pentose phosphate pathway in those 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
17 
 
cells [122]. In the 90’s, new functions for the lactate produced in the testis were 
described. Intratesticular lactate infusion was reported to improve the spermatogenesis 
in adult cryptorchid rat testis [123] and later, it was described that germ cell death is 
inhibited in a dose-dependent way by lactate [124]. Therefore, any condition that 
promotes an alteration in testicular lactate levels or lactate production by SCs may 
compromise germ cell development and this can occur through several distinct 
mechanisms.   
Recently, in vitro works focused on the molecular mechanisms of glucose or insulin 
deprivation in SCs. It was reported that decreased glucose levels in SCs culture 
medium increases glucose uptake to maintain lactate production, which was only slight 
decreased [55]. This was achieved by modulating GLUT1 and GLUT3 expression, 
through activation of AMP-activated protein kinase (AMPK), phosphatidylinositol 3-
kinase (PI3K)/PKB, and p38 MAPK-dependent pathways [55]. The authors do not infer 
about possible alterations in the key steps of glycolysis. One of those steps would be 
the conversion of fructose 6-phosphate to fructose 1,6-biphosphate by 
phosphofructokinase (PFK) as well as LDH action, which is responsible for the 
interconversion of lactate into pyruvate. Finally, the effect on the mechanisms of lactate 
export by MCTs remained to be elucidated. Nevertheless, that work was pioneer in 
evidencing that S s can adapt their glucose metabolism by modulating GLUTs 
expression. Interestingly, as discussed earlier, the same behavior in GLUTs expression 
was recently described in human SCs cultured in insulin deprivation conditions [54]. 
That work was one of the first attempts to disclose the mechanisms by which insulin 
deprivation or insulin resistance, that are common DM features, alter carbohydrate 
metabolism, namely glucose metabolism. In insulin-deprived cells, total glucose uptake 
was not altered, mainly due to the discussed GLUTs adaptation, but pyruvate 
consumption was compromised. The insulin-deprived cells not only stopped to 
consume pyruvate but started to produce this substrate that was then exported into the 
extracellular medium [54]. Consequently, lactate production was compromised and two 
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mechanisms of lactate metabolic control were found to be altered: LDH and MCT4. 
Moreover, it was later proposed that SCs could produce and export acetate to the 
developing germ cells and that this acetate production could also be regulated by 
external insulin [59]. In fact, it was reported that cultured human SCs secreted high 
amounts of acetate that was suppressed by insulin deprivation, through a mechanism 
mediated by the modulation of Acetyl-CoA synthase and Acetyl-CoA hydrolase 
expression. Therefore, at least in vitro, the molecular mechanisms of testicular glucose 
metabolism are severely altered by glucose and insulin fluctuations in ways that can 
compromise spermatogenesis. 
Although the exact mechanisms by which DM alters the glucose metabolism in 
testicular cells are not easy to follow in vivo, in vitro evidence cannot be disregarded 
even those dispersed and indirect. As discussed above, it is well known that DM is a 
metabolic disease that induces crucial alterations in sex hormones levels [125]. Recent 
work in both, rat and human SCs, showed that their energy metabolism is influenced by 
sex steroid hormones. Cells treated with 5α-Dihydrotestosterone (DHT) consumed less 
glucose and thus, produced less lactate. Both, 17β-estradiol (E2) and DHT were able 
to alter lactate metabolism-associated gene transcript levels such as MCT4, LDH and 
also GLUTs [49, 50]. Moreover, sex steroids are also known to regulate apoptotic 
signaling pathways in SCs thus deregulated levels of these hormones may lead to 
apoptosis and necrosis [126, 127]. Nonetheless, when analyzing all these molecular 
mechanisms that are certainly related to DM pathological conditions, one cannot 
neglect the possible contribution of glycogen. It has been reported that SCs possess 
glycogen and glycogen phosphorylase activity [128, 129] but these reports from the 
80’s were not consolidated and therefore should deserve special attention in a near 
future to understand the adaptive mechanisms of SCs in pathological conditions. The 
presence of glycogen and glycogen metabolism related machinery can be a valuable 
mechanism to explain some of the assumptions concerning DM-related effects in 
glucose testicular cells.  
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7. Role of alternative fuels and oxidative stress in testis from male diabetics 
As discussed earlier, euglycemia is very difficult to achieve and maintain in diabetic 
individuals that often face hyper- and hypoglycemia. Those fluctuations in insulin and 
glucose concentrations lead to several problems. Under glucose deprivation and/or 
insulin deregulation, testicular cells are expected to suffer metabolic adaptations and 
use alternative substrates. In fact, the role of these alternative substrates is 
underestimated when analyzing some of the available data. SCs have an enormous 
metabolic plasticity and can use several metabolic substrates such as palmitate and 
ketone bodies as well as glutamine, alanine, leucine, glycine and valine [130, 131]. 
Besides, these cells can produce ATP via the β-oxidation of free fatty acids or even 
through recycled lipids from apoptotic spermatogenic cells and residual bodies [132]. 
DM is known to induce severe alterations in lipid metabolism and studies in mice with 
inactivated genes of lipid metabolism proved that lipid metabolism are essential for a 
normal spermatogenesis [133]. Therefore, although there is a lack of literature 
regarding the use of these alternative substrates in testicular cells of diabetic 
individuals, we cannot disregard their contribution to the overall metabolic dysfunction 
that occurs in the testis of diabetic individuals. 
There are also growing evidence that DM increases cellular oxidative stress due to the 
overproduction of reactive oxygen species (ROS) and decreased antioxidant efficiency 
[134]. This is a direct consequence of increased glycolytic capacity induced by higher 
glucose availability. Therefore, in testicular cells such as SCs where glucose 
metabolism is very active to produce lactate, it is expected increased levels of oxidative 
stress. This is an issue that deserves special attention in the near future because ROS 
generation has a real potential toxic effect in sperm quality and function. High levels of 
ROS are reported to be detrimental to fertility potential in natural and assisted 
conception [135]. Moreover, ROS production stimulated by hyperglycemia is 
recognized as a major cause for the clinical complications associated with DM and 
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obesity [136]. Hyperglycemia-induced superoxide overproduction inhibits glucose-6-
phosphate dehydrogenase [137] thus decreasing the antioxidant defenses and ROS 
overproduction and is also intimately related with mitochondrial dysfunction. It has been 
reported that mitochondrial fission/fusion machinery is sensitive to the increased ROS 
production after hyperglycemia stimulation [138] and mitochondrial testicular 
antioxidant capacity is also known to be modulated by DM as an adaptive response to 
the increased oxidative stress [139]. In fact, hyperglycemia was reported to induce 
important alterations in sperm concentration and motility by altering energy production 
and free radical management [91], which is associated with the fact that human 
spermatozoa are known to be highly sensitive to oxidative stress. Sperm plasma 
membrane and nuclear or mitochondrial DNA fragmentation also occur in response to 
ROS, compromising the fertility potential of the individuals [140]. Increased sperm DNA 
damage was reported in diabetic men in reproductive age and associated to high 
oxidative stress resulting from sperm overexposure to glucose [5]. These mechanisms 
of sperm nuclear DNA damage in diabetic men promoted by ROS are suggested to be 
mediated through advanced glycation end products (AGEs) [141] and these AGEs 
accumulate in the reproductive tract of diabetic men [142]. Moreover, increased 
oxidative stress and higher DNA fragmentation is interconnected with apoptosis [143, 
144], which has been reported to be increased in sperm from T1D and T2D men and 
suggested as a possible mechanism to explain subfertility in these individuals [145]. 
Recently, a possible central role for ROS in the pathogenesis of insulin resistance has 
also been highlighted [146], thus evidencing that ROS production stimulated by DM 
may have roles that go far beyond the glucose transport and metabolism. 
 
8. Conclusion 
It is obvious that not all diabetic men are infertile and there are conflicting results 
concerning the effect of DM in sperm parameters but, even when conventional sperm 
parameters do not differ, the glucose transport mechanisms are expected to be altered. 
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Glucose availability and/or insulin dysfunction induced by DM are expected to induce 
important metabolic adaptations in testicular cells, besides changes in oxidative stress 
that are often reflected in mitochondrial and nuclear DNA fragmentation. Moreover, 
glucose metabolism is as important for testicular cells as for mature sperm. In fact, 
sperm hyperactivation and/or capacitation depend of this substrate, although it is not 
clear if glucose is necessary for direct energy production or as a precursor for other 
metabolic products [147]. Besides, it remains to be disclosed the mechanisms 
responsible for the DM-induced alterations in these processes. Although we have to 
admit that from a clinical perspective the knowledge of the molecular mechanisms 
beyond glucose transport are not as appellative as DNA integrity and oxidative stress, 
which seem to have a more direct effect in natural and assisted conception, disclosing 
the pathways by which the chronic metabolic changes, beyond glucose transport, are 
altered by DM in testicular cells, will open new possibilities for pharmacological 
intervention. The presence of several DM-related comorbidities also complicates the 
study of DM-induced alterations in testicular cells and sperm. Most of the time the 
patients are treated in a polypharmacy regimen and the inappropriate use of these 
agents are associated with significant morbidity and mortality [148]. This is a crucial 
point that, in some cases, is not correctly weighed in clinical studies. The possible 
subtle molecular alterations in the male reproductive health promoted by 
pharmacological agents currently used in DM treatment should also deserve special 
attention in the near future.  
In conclusion, the effects of DM on the molecular mechanisms responsible for the 
maintenance of the male reproductive health have been somewhat neglected, apart 
from the concerns about impotence, semen quality and, at some extend, oxidative 
stress and DNA fragmentation. Nevertheless, studies on the molecular mechanisms 
beyond glucose transport in DM-related male infertility will be on the spotlight in the 
next few years to uncover the metabolic plasticity in sperm and testicular cells of 
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diabetic individuals. This will certainly be a step forward for a possible metabolic 
therapeutic intervention. 
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Figure Legends 
 
Figure 1. Schematic illustration of the metabolic cooperation between Sertoli and germ 
cells. The glucose from the interstitial fluid enters the Sertoli cells through glucose 
transporters, mainly GLUT1 and GLUT3, and is converted into glucose-6-phosphate 
that is then converted into pyruvate by phosphofructokinase (PFK). The pyruvate can 
then be: a) transported into the mitochondrial matrix to form Acetyl-CoA; b) converted 
into lactate by lactate dehydrogenase (LDH); or c) converted into alanine by alanine 
aminotransferase (ALT). The lactate produced by Sertoli cells is exported to the 
intratubular fluid by proton-linked plasma membrane transporters (MCTs), mainly 
MCT4. The germ cells uptake the lactate produced by Sertoli cells through MCTs, 
which is then directed for ATP production.  
 
Figure 2. Schematic illustration of the insulin action in Sertoli cells metabolic pathways. 
The insulin effects, mediated by its interaction with insulin receptors, can induce 
several effects in metabolism-associated transporters. Some of those effects can be 
stimulatory, such as in monocarboxylate transporter 4 (MCT4), glucose transporter 3 
(GLUT3), lactate dehydrogenase (LDH), acetyl-CoA synthase and acetyl-CoA 
hydrolase; while other effects can be inhibitory such as in glucose transporter 1 
(GLUT1) and arachidonic acid synthesis.  - Stimulatory effect; - inhibitory effect.  
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Tables 
Table 1. Summary of the main studies reporting diabetes-related reproductive effects. 
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Table 1. Summary of the main studies reporting diabetes-related reproductive effects. 
 Model 
Type of 
Diabetes 
Reproductive Effects 
 A
n
im
a
l 
S
tu
d
ie
s
 
G
e
n
e
ti
c
 M
o
d
e
ls
 
BB Rat T1D 
 Testis weight 87 
Severe germ-cell depletion 
85 
 Serum testosterone 85,87 
Disruption of seminiferous tubular morphology 
85, 87 
Sertoli-cell vacuolization 
85
 
 Sperm production 87 
 Fertility 84,87 
GK Rat T2D Decreased sperm production
 91
 
C
h
e
m
ic
a
lly
-I
n
d
u
c
e
d
 M
o
d
e
ls
 
 
STZ Rat  
T1D 
 
 Testis weight 86,90 
Disruption of epididymis morphology and density 
89
 
 LH, FSH and testosterone serum levels 86, 88, 90 
 Sperm production 88, 89 
 Sperm counts and motility 86, 88, 90, 91, 92 
Erectile dysfunction
 70
 
Ejaculation dysfunction 
88, 90
 
 Mating behaviour 88, 90 
 Fertility 90, 92 
ALX Rat  T2D 
 LH, FSH and testosterone serum levels 93 
Disruption of seminiferous tubular morphology 
93 
 Number of Leydig and Sertoli cells 93 
 Number of spermatogonia 93 
C
li
n
ic
a
l 
S
tu
d
ie
s
                                                                            T1D 
Disruption of seminiferous tubular morphology 
78
 
Germ-cell depletion and Sertoli-cell vacuolization 
78
 
Disruption of Blood-Testis Barrier 
78
 
Erectile dysfunction 
70, 76
 
Ejaculation dysfunction 
73, 74
 
 Semen volume 76, 77 
 Sperm counts, motility and morphology 75, 76, 77 
                             T2D 
Erectile dysfunction 
69 
 Semen volume 5, 79 
 Sperm motility 79 
 Sperm DNA fragmentation 79  
Legend: BB Rat – BioBreeding genetic rodent model; GK Rats – Goto-Kakizaki genetic rodent 
model; STZ rat – Streptozotocin-induced rodent model; ALX rat – Alloxan-induced rodent 
model. T1D – type 1 diabetes; T2D – type 2 diabetes;  - increase;  - decrease; superscript 
numbers are references as indicated in references section. 
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Highlights 
 The increasing incidence of Diabetes (DM) is affecting men in reproductive age. 
 DM associated male subfertility/infertility will dramatically rise. 
 DM may compromise the metabolic cooperation between testicular cells.   
 Insulin (de)regulation is a major player in male reproductive health. 
 Effects of DM on testicular metabolic pathways have been somewhat neglected. 
